Zydus Lifesciences Limited (ZYDUSLIFE) receives USFDA approval for Estradiol and Levonorgestrel Transdermal System, gaining 180-day CGT exclusivity.
Zydus Lifesciences Limited (ZYDUSLIFE) signs agreement with Sri Lanka's Board of Investment to build a pharmaceutical manufacturing facility.
Zydus Lifesciences Limited (ZYDUSLIFE) announces the conclusion of USFDA inspection at its Moraiya plant, with 5 observations noted.
Zydus Lifesciences Limited (ZYDUSLIFE) announces USFDA acceptance of FYB206, a biosimilar to Keytruda®.
Zydus Lifesciences Limited (ZYDUSLIFE) unveils new post hoc analysis from Phase 3 EPICS-III trial, showing greater biochemical response with saroglitazar.
Zydus Lifesciences Limited (ZYDUSLIFE) partners with MSN to launch the first generic Adempas® in the U.S.
Zydus Lifesciences Limited (ZYDUSLIFE) announces USFDA inspection conclusion at Ahmedabad plant with one observation, no data integrity issues.